Is Catalyst Pharmaceuticals (CPRX) Pricing Reflect Long Term Value After Rare Disease Interest? [Yahoo! Finance]
Catalyst Pharmaceuticals, Inc. (CPRX)
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.catalystpharma.com
Company Research
Source: Yahoo! Finance
If you are looking at Catalyst Pharmaceuticals and wondering whether the recent price level offers good value, this article will walk through what the current market price might be implying. The stock last closed at US$23.23, with returns of 0.3% year to date, 10.5% over 1 year, 45.9% over 3 years, and a very large gain over 5 years. This comes alongside recent 7 day and 30 day declines of 4.2% and 4.5%. Recent news around Catalyst Pharmaceuticals has focused on its role in the pharmaceuticals and biotech space and ongoing interest in rare disease treatments. This helps explain why the share price has been active rather than quiet. This context matters because investors are reacting not only to company specific developments but also to how the broader market values similar businesses. Catalyst Pharmaceuticals currently has a valuation score of 6 out of 6 . Next we will walk through what different valuation approaches say about the stock and then finish with a tool that can help
Show less
Read more
Impact Snapshot
Event Time:
CPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPRX alerts
High impacting Catalyst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CPRX
News
- A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Softness [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals Touts Firdapse Growth, Agamree Traction as Fycompa Faces Generics [Yahoo! Finance]Yahoo! Finance
- Full Year 2025 Trading Update [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Catalyst Pharmaceuticals: Exceptional Fundamentals Trading at 20-33% Discount [Yahoo! Finance]Yahoo! Finance
CPRX
Earnings
- 2/25/26 - Beat
CPRX
Sec Filings
- 3/19/26 - Form 8-K/A
- 3/18/26 - Form 8-K
- 2/25/26 - Form 8-K
- CPRX's page on the SEC website